EP1106180B1
(en)
|
1999-12-08 |
2003-11-12 |
Centre National de la Recherche Scientifique (CNRS) |
Use of hymenialdisine or derivatives thereof in the manufacture of medicaments
|
TWI297335B
(en)
|
2001-07-10 |
2008-06-01 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
TWI252847B
(en)
|
2001-07-10 |
2006-04-11 |
Synta Pharmaceuticals Corp |
Synthesis of taxol enhancers
|
TWI332943B
(en)
|
2001-07-10 |
2010-11-11 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
TWI330079B
(en)
|
2003-01-15 |
2010-09-11 |
Synta Pharmaceuticals Corp |
Treatment for cancers
|
CN1849318B
(zh)
|
2003-07-30 |
2011-10-12 |
里格尔药品股份有限公司 |
用2,4-嘧啶二胺化合物预防和治疗自体免疫疾病的方法
|
US7557113B2
(en)
*
|
2003-08-26 |
2009-07-07 |
Teijin Pharma Limited |
Substituted pyrrolo[3,2-d]pyrimidine derivatives
|
WO2005061519A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
CN101676285A
(zh)
*
|
2004-03-30 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
用作jak和其它蛋白激酶抑制剂的氮杂吲哚
|
TW200604168A
(en)
|
2004-04-02 |
2006-02-01 |
Vertex Pharma |
Azaindoles useful as inhibitors of rock and other protein kinases
|
JP2007533753A
(ja)
*
|
2004-04-23 |
2007-11-22 |
タケダ サン ディエゴ インコーポレイテッド |
インドール誘導体及びキナーゼ阻害剤としてのその使用
|
US7385084B2
(en)
|
2004-06-23 |
2008-06-10 |
Synta Pharmaceutical Corp. |
Bis(thio-hydrazide amide) salts for treatment of cancers
|
AU2005260689B2
(en)
*
|
2004-06-30 |
2012-05-10 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of protein kinases
|
EP1778687A2
(en)
|
2004-07-27 |
2007-05-02 |
SGX Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
US7626021B2
(en)
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
NZ553267A
(en)
|
2004-07-27 |
2010-09-30 |
Sgx Pharmaceuticals Inc |
Pyrrolo-pyridine kinase modulators
|
US7709645B2
(en)
|
2004-07-27 |
2010-05-04 |
Sgx Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
US7550598B2
(en)
*
|
2004-08-18 |
2009-06-23 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
US7713973B2
(en)
*
|
2004-10-15 |
2010-05-11 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
NZ555566A
(en)
*
|
2004-11-22 |
2009-12-24 |
Vertex Pharma |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
NZ560712A
(en)
*
|
2005-02-17 |
2010-12-24 |
Synta Pharmaceuticals Corp |
(3,4,5-trisubstituted-phenyl)isoxazole combretastin derivatives for the treatment of disorders
|
JP2008536875A
(ja)
|
2005-04-15 |
2008-09-11 |
シンタ ファーマシューティカルズ コーポレーション |
ビス(チオヒドラジド)アミド化合物による併用癌療法
|
US8921376B2
(en)
*
|
2005-05-20 |
2014-12-30 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
KR101312225B1
(ko)
|
2005-06-08 |
2013-09-26 |
리겔 파마슈티칼스, 인크. |
Jak 경로의 억제를 위한 조성물 및 방법
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
EP2251341A1
(en)
|
2005-07-14 |
2010-11-17 |
Astellas Pharma Inc. |
Heterocyclic Janus kinase 3 inhibitors
|
JP5071374B2
(ja)
|
2005-07-14 |
2012-11-14 |
アステラス製薬株式会社 |
ヘテロ環ヤヌスキナーゼ3阻害剤
|
EP1928437A2
(en)
|
2005-08-26 |
2008-06-11 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
JP5131688B2
(ja)
*
|
2005-09-20 |
2013-01-30 |
学校法人日本大学 |
高親和性IgE受容体γ鎖転写調節
|
SG151327A1
(en)
*
|
2005-09-30 |
2009-04-30 |
Vertex Pharmaceuticals Incopor |
Deazapurines useful as inhibitors of janus kinases
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
US8247556B2
(en)
*
|
2005-10-21 |
2012-08-21 |
Amgen Inc. |
Method for preparing 6-substituted-7-aza-indoles
|
EP2314289A1
(en)
|
2005-10-31 |
2011-04-27 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
EP1966222A2
(en)
*
|
2005-11-16 |
2008-09-10 |
SGX Pharmaceuticals, Inc. |
Pyrazolothiazole protein kinase modulators
|
CA2634787C
(en)
*
|
2005-12-23 |
2014-10-21 |
Smithkline Beecham Corporation |
Azaindole inhibitors of aurora kinases
|
EP2537849A3
(en)
|
2006-01-17 |
2013-04-03 |
Vertex Pharmaceuticals, Inc. |
Azaindoles useful as inhibitors of janus kinases
|
JP2009528295A
(ja)
|
2006-02-24 |
2009-08-06 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Jak経路の阻害のための組成物および方法
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
US8741912B2
(en)
*
|
2006-04-05 |
2014-06-03 |
Vertex Pharmaceuticals Incorporated |
Deazapurines useful as inhibitors of Janus kinases
|
EP2026813A2
(en)
|
2006-05-09 |
2009-02-25 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
EP2377531A2
(en)
|
2006-05-09 |
2011-10-19 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
EP2046119A2
(en)
*
|
2006-07-07 |
2009-04-15 |
Myriad Genetics, Inc. |
Treatment of psychiatric disorders
|
WO2008021781A1
(en)
|
2006-08-07 |
2008-02-21 |
Incyte Corporation |
Triazolotriazines as kinase inhibitors
|
EP2057117A2
(en)
|
2006-08-21 |
2009-05-13 |
Synta Pharmaceuticals Corporation |
Compounds for treating proliferative disorders
|
JP2010502616A
(ja)
|
2006-08-31 |
2010-01-28 |
シンタ ファーマシューティカルズ コーポレーション |
癌を治療するためのビス(チオヒドラジドアミド)の組み合わせ
|
WO2008030651A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
EP2059250A2
(en)
*
|
2006-09-14 |
2009-05-20 |
Synta Pharmaceuticals Corporation |
Compounds for the treatment of angiogenesis
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
JP2010505962A
(ja)
|
2006-10-09 |
2010-02-25 |
武田薬品工業株式会社 |
キナーゼ阻害剤
|
EP2684874B1
(en)
|
2006-10-23 |
2017-05-17 |
Cephalon, Inc. |
Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
KR101532256B1
(ko)
|
2006-11-22 |
2015-06-29 |
인사이트 코포레이션 |
키나제 억제제로서의 이미다조트리아진 및 이미다조피리미딘
|
WO2008079346A1
(en)
|
2006-12-21 |
2008-07-03 |
Vertex Pharmaceuticals Incorporated |
5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
GB0702265D0
(en)
*
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-Azaindole derivatives
|
CN101679436A
(zh)
*
|
2007-04-10 |
2010-03-24 |
Sgx药品公司 |
稠环杂环激酶调节剂
|
CA2695004C
(en)
|
2007-07-17 |
2016-01-19 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
JP4691669B2
(ja)
|
2007-08-22 |
2011-06-01 |
アストラゼネカ・アクチエボラーグ |
シクロプロピルアミド誘導体
|
WO2009064422A2
(en)
*
|
2007-11-13 |
2009-05-22 |
Angion Biomedica Corp. |
Hepatocyte growth factor pathway activators in fibrotic connective tissue diseases
|
CA2709806A1
(en)
*
|
2008-01-22 |
2009-07-30 |
Merck Patent Gmbh |
Protein kinase inhibitors and use thereof
|
PL2265607T3
(pl)
|
2008-02-15 |
2017-07-31 |
Rigel Pharmaceuticals, Inc. |
Związki pirymidyno-2-aminowe i ich zastosowanie jako inhibitory kinaz JAK
|
NZ589315A
(en)
|
2008-04-16 |
2012-11-30 |
Portola Pharm Inc |
2,6-diamino-pyrimidin-5-yl-carboxamides as Spleen tryosine kinase (syk) or Janus kinase (JAK) inhibitors
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
CA2723185A1
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
HUE034716T2
(hu)
|
2008-05-21 |
2018-02-28 |
Incyte Holdings Corp |
2-Fluor-N-metil-4-[7-(kinolin-6-il-metil)-imidazo[1,2-b][1,2,4]triazin-2-il]benzamid sói és eljárások ezek elõállítására
|
AR072008A1
(es)
*
|
2008-06-13 |
2010-07-28 |
Merck & Co Inc |
Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38
|
WO2009157196A1
(ja)
|
2008-06-25 |
2009-12-30 |
武田薬品工業株式会社 |
アミド化合物
|
AU2009274023A1
(en)
*
|
2008-07-23 |
2010-01-28 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
DE102008038221A1
(de)
*
|
2008-08-18 |
2010-02-25 |
Merck Patent Gmbh |
7-Azaindolderivate
|
CN102264721B
(zh)
|
2008-11-10 |
2015-12-09 |
沃泰克斯药物股份有限公司 |
用作atr激酶抑制剂的化合物
|
EP2379561B1
(en)
|
2008-11-25 |
2015-11-04 |
University Of Rochester |
Mlk inhibitors and methods of use
|
KR101745331B1
(ko)
|
2008-12-19 |
2017-06-09 |
버텍스 파마슈티칼스 인코포레이티드 |
Atr 키나제의 억제제로서 유용한 피라진 유도체
|
TW201039825A
(en)
|
2009-02-20 |
2010-11-16 |
Astrazeneca Ab |
Cyclopropyl amide derivatives 983
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
NZ594398A
(en)
|
2009-04-03 |
2014-03-28 |
Plexxikon Inc |
Propane-1-sulfonic acid (3-[5-(4-chloro-phenyl)-1h-pyrrol [2, 3-b] pyridine-3-carbonyl]-2,4-difluoro-phenyl} -amide compositions and uses thereof
|
RS55341B1
(sr)
|
2009-06-17 |
2017-03-31 |
Vertex Pharma |
Inhibitori replikacije virusa gripa
|
US8329724B2
(en)
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
US20110112127A1
(en)
|
2009-11-06 |
2011-05-12 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
BR112012019302B1
(pt)
|
2010-02-03 |
2022-06-21 |
Incyte Holdings Corporation |
Imidazo[1,2-b] [1,2,4]triazinas como inibidores de c-met, composição que as compreende e métodos in vitro de inibir a atividade de c-met cinase, de inibir a via de sinalização da hgf/c-met cinase em uma célula e de inibir a atividade proliferativa de uma célula
|
TWI520945B
(zh)
|
2010-02-18 |
2016-02-11 |
阿斯特捷利康公司 |
環丙基苯甲醯胺衍生物之新穎結晶形式
|
AU2011218490B9
(en)
*
|
2010-02-18 |
2014-12-18 |
Astrazeneca Ab |
Solid forms comprising a cyclopropyl amide derivative
|
WO2011143419A1
(en)
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Pyrazines useful as inhibitors of atr kinase
|
US9334244B2
(en)
|
2010-05-12 |
2016-05-10 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
JP2013526538A
(ja)
|
2010-05-12 |
2013-06-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用な化合物
|
EP2569284B1
(en)
|
2010-05-12 |
2015-07-08 |
Vertex Pharmaceuticals Incorporated |
2-aminopyridine derivatives useful as inhibitors of atr kinase
|
JP2013529200A
(ja)
|
2010-05-12 |
2013-07-18 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用な化合物
|
NZ603477A
(en)
|
2010-05-12 |
2014-09-26 |
Vertex Pharma |
Compounds useful as inhibitors of atr kinase
|
NZ604306A
(en)
|
2010-05-17 |
2015-02-27 |
Incozen Therapeutics Pvt Ltd |
Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
|
CA2800176C
(en)
|
2010-05-24 |
2018-08-28 |
University Of Rochester |
Bicyclic heteroaryl kinase inhibitors and methods of use
|
AU2011270807A1
(en)
*
|
2010-06-23 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo- pyrazine derivatives useful as inhibitors of ATR kinase
|
EP2601192B1
(en)
|
2010-08-04 |
2017-03-01 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds
|
DE102010049877A1
(de)
*
|
2010-11-01 |
2012-05-03 |
Merck Patent Gmbh |
7-((1,2,3)Triazol-4-yl)-pyrrolo(2,3) pyrazinderivate
|
US9102625B2
(en)
|
2010-11-01 |
2015-08-11 |
Portola Pharmaceuticals, Inc. |
Nicotinamides as JAK kinase modulators
|
EP2649065A1
(en)
|
2010-12-09 |
2013-10-16 |
Amgen Inc. |
Bicyclic compounds as pim inhibitors
|
CN103492381A
(zh)
|
2010-12-16 |
2014-01-01 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
CN103562205A
(zh)
*
|
2010-12-16 |
2014-02-05 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
DE102011008352A1
(de)
*
|
2011-01-12 |
2012-07-12 |
Merck Patent Gmbh |
5-([1,2,3]Triazol-4-yl)-7H-pyrrolo-[2,3-d]pyrimidinderivate
|
ES2696023T3
(es)
|
2011-02-07 |
2019-01-11 |
Plexxikon Inc |
Compuestos y métodos para la modulación de quinasas e indicaciones para ello
|
AR085279A1
(es)
|
2011-02-21 |
2013-09-18 |
Plexxikon Inc |
Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
|
MX2013010771A
(es)
|
2011-03-22 |
2014-01-31 |
Amgen Inc |
Compuestos de azoles como inhibidores.
|
KR20140027974A
(ko)
|
2011-04-05 |
2014-03-07 |
버텍스 파마슈티칼스 인코포레이티드 |
Tra 키나제의 억제제로서 유용한 아미노피라진 화합물
|
EP2706852B1
(en)
|
2011-05-10 |
2018-08-22 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as syk inhibitors
|
KR20140028062A
(ko)
|
2011-05-10 |
2014-03-07 |
머크 샤프 앤드 돔 코포레이션 |
Syk 억제제로서의 아미노피리미딘
|
AU2012253886A1
(en)
|
2011-05-10 |
2013-10-31 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as Syk inhibitors
|
EP2723745A1
(en)
|
2011-06-22 |
2014-04-30 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
US9309250B2
(en)
|
2011-06-22 |
2016-04-12 |
Vertex Pharmaceuticals Incorporated |
Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors
|
JP2014522818A
(ja)
|
2011-06-22 |
2014-09-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用な化合物
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
US9012642B2
(en)
*
|
2011-09-22 |
2015-04-21 |
Viiv Healthcare Uk Limited |
Pyrrolopyridinone compounds and methods for treating HIV
|
WO2013049719A1
(en)
|
2011-09-30 |
2013-04-04 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
ES2899880T3
(es)
|
2011-09-30 |
2022-03-15 |
Vertex Pharma |
Tratamiento de cáncer de páncreas y cáncer de pulmón de células no pequeñas con inhibidores de ATR
|
HUE046429T2
(hu)
|
2011-09-30 |
2020-03-30 |
Vertex Pharma |
ATR kináz inhibítoraként használható vegyületek elõállítására szolgáló eljárás
|
AU2012315611A1
(en)
|
2011-09-30 |
2014-04-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
WO2013049720A1
(en)
|
2011-09-30 |
2013-04-04 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2013052391A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
WO2013052394A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
US8987456B2
(en)
|
2011-10-05 |
2015-03-24 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
WO2013071093A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
EP2776422A1
(en)
|
2011-11-09 |
2014-09-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2013071094A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP2776419B1
(en)
|
2011-11-09 |
2016-05-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
WO2013071088A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
EP2782579B1
(en)
|
2011-11-23 |
2019-01-02 |
Portola Pharmaceuticals, Inc. |
Pyrazine kinase inhibitors
|
US9815831B2
(en)
|
2012-03-30 |
2017-11-14 |
Rhizen Pharmaceuticals Sa |
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
|
IN2014KN02410A
(ja)
|
2012-04-05 |
2015-05-01 |
Vertex Pharma |
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
EA201492250A1
(ru)
|
2012-06-01 |
2015-08-31 |
Такеда Фармасьютикал Компани Лимитед |
Гетероциклическое соединение
|
EP2904406B1
(en)
|
2012-10-04 |
2018-03-21 |
Vertex Pharmaceuticals Incorporated |
Method for measuring atr inhibition mediated increases in dna damage
|
US9676756B2
(en)
|
2012-10-08 |
2017-06-13 |
Portola Pharmaceuticals, Inc. |
Substituted pyrimidinyl kinase inhibitors
|
EP2909202A1
(en)
|
2012-10-16 |
2015-08-26 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
WO2014085795A1
(en)
|
2012-11-30 |
2014-06-05 |
University Of Rochester |
Mixed lineage kinase inhibitors for hiv/aids therapies
|
EP3418281B1
(en)
|
2012-12-07 |
2020-09-30 |
Vertex Pharmaceuticals Inc. |
Pyrazolo[1,5-a]pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases
|
WO2014165143A1
(en)
*
|
2013-03-12 |
2014-10-09 |
Abbvie Inc. |
Dihydro-pyrrolopyridinone bromodomain inhibitors
|
EP2970286A1
(en)
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Inc. |
Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
|
US9206188B2
(en)
*
|
2013-04-18 |
2015-12-08 |
Arrien Pharmaceuticals Llc |
Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors
|
AR096758A1
(es)
*
|
2013-06-28 |
2016-02-03 |
Abbvie Inc |
Inhibidores cristalinos de bromodominios
|
LT3052096T
(lt)
|
2013-10-03 |
2018-04-10 |
Kura Oncology, Inc. |
Erk inhibitoriai ir jų panaudojimo būdai
|
DK3421468T3
(da)
|
2013-11-13 |
2021-01-11 |
Vertex Pharma |
Fremgangsmåder til fremstilling af inhibitorer af re-plikation af influenzavira
|
NZ719729A
(en)
|
2013-11-13 |
2022-04-29 |
Vertex Pharma |
Inhibitors of influenza viruses replication
|
MX370390B
(es)
|
2013-12-06 |
2019-12-11 |
Vertex Pharma |
Compuesto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]pirazolo[1, 5-a]pirimidin-3-carboxamida util como inhibidor de cinasa de ataxia telangiectasia mutada (atm) y rad3 relacionados (atr), su preparacion, diferentes formas solidas y sus derivados radiomarcados.
|
EP3083560B1
(en)
|
2013-12-20 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
EP3083559B1
(en)
|
2013-12-20 |
2021-03-10 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
EP3082807B1
(en)
|
2013-12-20 |
2018-07-04 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
JP5938533B2
(ja)
*
|
2014-02-04 |
2016-06-22 |
大鵬薬品工業株式会社 |
アザインドール誘導体
|
US9775839B2
(en)
|
2014-03-13 |
2017-10-03 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
CA2945263A1
(en)
|
2014-04-09 |
2015-10-15 |
Christopher Rudd |
Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity
|
CN110590787A
(zh)
|
2014-06-05 |
2019-12-20 |
沃泰克斯药物股份有限公司 |
Atr激酶抑制剂的制备方法及其不同的固体形式
|
JP6936007B2
(ja)
|
2014-06-17 |
2021-09-15 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
Chk1阻害剤とatr阻害剤との組み合わせを使用してがんを処置する方法
|
EP3053927A1
(en)
*
|
2015-02-05 |
2016-08-10 |
Vectura Limited |
Novel polymorphs
|
EP3294735B8
(en)
|
2015-05-13 |
2022-01-05 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
WO2016183116A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing inhibitors of influenza viruses replication
|
MX2018003657A
(es)
|
2015-09-30 |
2018-04-30 |
Vertex Pharma |
Metodo para tratar cancer usando una combinacion de agentes que dañan el adn e inhibidores de proteina relacionada con ataxia telangiectasia y rad3 (atr).
|
EP3170822A1
(en)
|
2015-11-18 |
2017-05-24 |
AGV Discovery |
Azaindole derivatives and their use as erk kinase inhibitors
|
CA3018802A1
(en)
*
|
2016-04-15 |
2017-10-19 |
Abbvie Inc. |
Bromodomain inhibitors
|
WO2018049214A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
WO2018049191A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridone derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
TW201811799A
(zh)
|
2016-09-09 |
2018-04-01 |
美商英塞特公司 |
吡唑并嘧啶化合物及其用途
|
IL292977A
(en)
|
2016-09-09 |
2022-07-01 |
Incyte Corp |
Pyrazolopyridine derivatives as modulators of hpk1 and their use in cancer therapy
|
US20180228786A1
(en)
|
2017-02-15 |
2018-08-16 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
WO2018217766A1
(en)
|
2017-05-22 |
2018-11-29 |
Whitehead Institute For Biomedical Research |
Kcc2 expression enhancing compounds and uses thereof
|
WO2018226846A1
(en)
*
|
2017-06-07 |
2018-12-13 |
Plexxikon Inc. |
Compounds and methods for kinase modulation
|
WO2019020981A1
(en)
*
|
2017-07-24 |
2019-01-31 |
Redag Crop Protection Ltd. |
PYRAZOLE, ISOTHIAZOLE AND ISOXAZOLE DERIVATIVES USEFUL AS AGRICULTURAL FUNGICIDES
|
WO2019051199A1
(en)
|
2017-09-08 |
2019-03-14 |
Incyte Corporation |
6-CYANO-INDAZOLE COMPOUNDS AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) MODULATORS
|
KR20190043437A
(ko)
|
2017-10-18 |
2019-04-26 |
씨제이헬스케어 주식회사 |
단백질 키나제 억제제로서의 헤테로고리 화합물
|
EP3305786A3
(de)
|
2018-01-22 |
2018-07-25 |
Bayer CropScience Aktiengesellschaft |
Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
|
US10752635B2
(en)
|
2018-02-20 |
2020-08-25 |
Incyte Corporation |
Indazole compounds and uses thereof
|
MD3755703T2
(ro)
|
2018-02-20 |
2022-10-31 |
Incyte Corp |
Derivați N-(fenil)-2-(fenil)pirimidin-4-carboxamidă și compuși înrudiți ca inhibitori HPK1 pentru tratarea cancerului
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
CN112243439A
(zh)
*
|
2018-06-13 |
2021-01-19 |
百济神州有限公司 |
作为hpk1抑制剂的吡咯并[2,3-b]吡啶或吡咯并[2,3-b]吡嗪及其用途
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
MA53726A
(fr)
|
2018-09-25 |
2022-05-11 |
Incyte Corp |
Composés pyrazolo[4,3-d]pyrimidine en tant que modulateurs des alk2 et/ou fgfr
|
US20220242870A1
(en)
*
|
2019-05-17 |
2022-08-04 |
Voronoi Inc. |
Heterocycle-fused pyrimidine derivative and use thereof
|
CA3147918A1
(en)
|
2019-08-06 |
2021-02-11 |
Incyte Corporation |
Solid forms of an hpk1 inhibitor
|
CN112625036A
(zh)
*
|
2019-10-08 |
2021-04-09 |
上海海和药物研究开发股份有限公司 |
一类具有brd4抑制活性的化合物、其制备方法及用途
|
EP4212531A1
(en)
|
2022-01-14 |
2023-07-19 |
AGV Discovery |
Azaindole derivatives and their use as erk kinase inhibitors
|